May 12, 2006 — /Pall/ — East Hills, NY and Tobelbad, Austria — Pall Corporation (NYSE: PLL) and zeta Holding GmbH announced today that they have entered into an agreement to collaborate in the use of specific automation software and development, supply and marketing of equipment packages for fermentation, recovery and purification of biotech products.
Under the terms of the agreement, software codes, which are developed and owned by zeta automation and currently used in its range of fermenters, may be used also in conjunction with Pall’s range of filtration, ultrafiltration and chromatography systems. The companies also agree to develop, co-market and distribute integrated product lines for laboratory and pilot-scale systems with common user interfaces and data acquisition. Each company may also continue to offer its products independently.
“This collaboration with zeta is a significant opportunity that gives our customers flexibility in the choice of fully integrated processes, or stand-alone packages with common features that have potential to shorten and simplify installation, training and validation,” says Ken Frank, President, Pall Biopharmaceuticals. “The ability to include fermentation within this scope is an ideal complement to Pall’s capabilities in total process solutions”.
“The agreed partnership with Pall enables zeta to extend our clientele for upstream systems and a consistent integration in downstream processes. Thus the full capability can be tapped. The benefits for our customers are the fully integrated solutions for biopharmaceutical systems from laboratory to production scale,” Norbert Pechstein, Managing Director of zeta Automation says. “Furthermore, this co-peration offers additionally the advantage of the distinctive worldwide sales network of our partner”.
About Pall Corporation
Pall is the global leader in the rapidly growing field of filtration, separations and purification. Pall’s business is organized around two broad markets: Life Sciences and Industrial. The Company provides leading-edge products to meet the demanding needs of customers in biotechnology, pharmaceuticals, transfusion medicines, semiconductors, water purification, aerospace and broad industrial markets. Total revenues for fiscal 2005 were $1.9 billion. The Company headquarters are in East Hills, New York with extensive operations throughout the world. Visit Pall at www.pall.com
About zeta Holding
zeta Holding is a supplier of system solutions and products for use in biotechnological and pharmaceutical product plants. The main emphasis of our activities lies in upstream processing plants. For these applications, zeta offers a large number of components and systems as standardised serial products as well as customer specific solutions. Further fields of activity are pure media systems, sterile plants as well as the assembly of biopharmaceutical plants, together with the appropriate automation. This business group with several European locations is active mainly on the European Market. More details about zeta can be found at www.zeta.com.